Table 2. Medication and PCI.
| Variables | CAC ≤300 (n=66) | CAC >300 (n=40) | P value |
|---|---|---|---|
| Optimal medical therapy (n, %) | |||
| Beta blockers | 22/33 | 14/35 | 0.861 |
| ACEI | 7/11 | 4/10 | 1.000 |
| ARB | 21/32 | 18/45 | 0.173 |
| aspirin | 52/79 | 32/80 | 0.881 |
| Statins | 58/88 | 35/88 | 1.000 |
| Glycoprotein IIb/IIIa inhibitor | 50/76 | 31/78 | 0.838 |
| Angiographic findings (n, %) | |||
| Single-vessel disease | 10/15 | 7/18 | 0.749 |
| Multi-vessel disease | 5/8 | 10/25 | 0.013 |
| Number of stents (n, %) | |||
| Single stent | 10/15 | 9/23 | 0.339 |
| Two stents | 4/6 | 6/15 | 0.237 |
| Three stents | 1/2 | 2/5 | 0.657 |
PCI, percutaneous coronary angiography; CAC, coronary artery calcification; ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin II receptor antagonists.